These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8384353)

  • 1. Protein phosphorylation required for the formation of E2F complexes regulates N-myc transcription during differentiation of human embryonal carcinoma cells.
    Hara E; Okamoto S; Nakada S; Taya Y; Sekiya S; Oda K
    Oncogene; 1993 Apr; 8(4):1023-32. PubMed ID: 8384353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferons and interleukin-6 suppress the DNA-binding activity of E2F in growth-sensitive hematopoietic cells.
    Melamed D; Tiefenbrun N; Yarden A; Kimchi A
    Mol Cell Biol; 1993 Sep; 13(9):5255-65. PubMed ID: 7689148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer.
    Suzuki M; Okuyama S; Okamoto S; Shirasuna K; Nakajima T; Hachiya T; Nojima H; Sekiya S; Oda K
    Oncogene; 1998 Aug; 17(7):853-65. PubMed ID: 9780002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM; Russo P; Venta-Perez G; Cordon-Cardo C; Rifkind RA; Marks PA
    Cancer Res; 1997 Jul; 57(13):2789-98. PubMed ID: 9205091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S; Shudo K; Takada S; Koike K
    Cell Growth Differ; 1995 Mar; 6(3):229-37. PubMed ID: 7794791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering.
    Alesse E; Zazzeroni F; Angelucci A; Giannini G; Di Marcotullio L; Gulino A
    Cell Death Differ; 1998 May; 5(5):381-9. PubMed ID: 10200487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of the cyclin A promoter in differentiating human embryonal carcinoma cells is mediated by depletion of ATF-1 and ATF-2 in the complex at the ATF/CRE site.
    Nakamura T; Okuyama S; Okamoto S; Nakajima T; Sekiya S; Oda K
    Exp Cell Res; 1995 Feb; 216(2):422-30. PubMed ID: 7843287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gene expression index c-myc x E2F-1/p21 is highly predictive of malignant phenotype in human bronchial epithelial cells.
    DeMuth JP; Jackson CM; Weaver DA; Crawford EL; Durzinsky DS; Durham SJ; Zaher A; Phillips ER; Khuder SA; Willey JC
    Am J Respir Cell Mol Biol; 1998 Jul; 19(1):18-24. PubMed ID: 9651176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in E2F DNA-binding activity during induced erythroid differentiation.
    Richon VM; Venta-Perez G
    Cell Growth Differ; 1996 Jan; 7(1):31-42. PubMed ID: 8788031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of nuclear factors with the regulatory region of the N-myc gene during differentiation of human embryonal carcinoma cells.
    Takehana K; Nakada S; Hara E; Taya Y; Sekiya S; Oda K
    Gene; 1991 Jul; 103(2):219-25. PubMed ID: 1840540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role for E2F1 in p210 BCR-ABL downstream regulation of c-myc transcription initiation. Studies in murine myeloid cells.
    Stewart MJ; Litz-Jackson S; Burgess GS; Williamson EA; Leibowitz DS; Boswell HS
    Leukemia; 1995 Sep; 9(9):1499-507. PubMed ID: 7658719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle gene expression and E2F transcription factor complexes in human melanoma cells induced to terminally differentiate.
    Jiang H; Lin J; Young SM; Goldstein NI; Waxman S; Davila V; Chellappan SP; Fisher PB
    Oncogene; 1995 Sep; 11(6):1179-89. PubMed ID: 7566979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
    Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
    Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG
    Oncogene; 1995 Nov; 11(9):1685-92. PubMed ID: 7478595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter.
    Spitkovsky D; Schulze A; Boye B; Jansen-Dürr P
    Cell Growth Differ; 1997 Jun; 8(6):699-710. PubMed ID: 9186003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The macromolecular state of the transcription factor E2F and glucocorticoid regulation of c-myc transcription.
    Rhee K; Ma T; Thompson EA
    J Biol Chem; 1994 Jun; 269(25):17035-42. PubMed ID: 8006008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F.
    Hiyama H; Iavarone A; Reeves SA
    Oncogene; 1998 Mar; 16(12):1513-23. PubMed ID: 9569018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.